OMRF is recruiting those who have or who think they may have Sjögren’s syndrome to participate in new research studies and a clinical trial.
According to the Lupus Foundation of America, more than 1.5 million Americans suffer from the disease.
The illness affects about 4,000 Americans, 80 percent of whom are women.
A recent OMRF study is potentially paving the way for better preventive treatment options for African American patients.
Multiple studies have show the drug is not effective at treating COVID-19, and in some cases can even cause heart problems.
James received the award for her contributions to understanding systemic autoimmune diseases such as lupus and rheumatoid arthritis.